Disruptive Capital for Disruptive Ideas
Cottonwood’s investment approach and focus is on hard science, pre-seed, seed and early-stage funding.
Geographical focus: Southwest USA (NM, AZ, UT, CO, TX) & Northern Europe (The Netherlands, Belgium, Germany, Finland, Sweden).
Investment focus: high tech technology / hard science (patent / IP based): robotics, photonics, telecom, optics, automotive, clean energy, sensor technology, high-tech health, nanotechnology, chemicals, advanced materials, etcetera. We focus on strong patents and therefore we do not invest in software or apps.
Average investment size: 1 – 3 M (pre-seed / seed / Series A). Cottonwood only invests in the founding / seed stage and together with partners and other investors in follow-on rounds of our own portfolio.
Cottonwood began working with me a year before they closed their first fund. Even though they weren’t initially in a position to invest they still opened doors to potential investors and customers, and assisted with the fund raising strategy and execution plan. Once their fund was closed they took an aggressive lead role in pulling together our first round and helping us launch the company. Now after having raised almost $150M they continue to support our growth, provide valuable advice and open doors to additional resources as we need them. We have been fortunate to have Cottonwood as a partner in building our company.
— Steve Krasulick, President & CEO, Skorpios Technologies, Inc.
Skorpios Technologies Inc.
Meet the Cottonwood team
Founder and Managing Director of Cottonwood Technology Fund I, II and Euro Fund, current IRR for Fund I on realized mark-ups – 50% + ; current value of Fund I already up 450%; anticipated cash-on-cash 6X +; better than prior Southeast results.
Founded and former Managing Director of Southeast Interactive, the first and largest information technology-focused fund based in the Southeast. Raised three funds totaling over $175 million.
Directly involved in fund raising and exit transaction events totaling in excess of $1 billion in enterprise value across the portfolio and generated cash on cash returns on directed investments of almost 4X.
Dave has extensive experience working with the National Labs and research universities in the Southwestern US, as well as nationally at the leadership and research-heads levels.
Dave holds a MBA from the Fuqua School of Business at Duke University.
Alain le Loux
Alain le Loux has 20+ years’ experience in Technology on board level positions (former member of the Executive committee of corporate Getronics PinkRoccade) and as CEO of startups.
Alain studied at the technical University of Twente and graduated in 1994 with a double degree. Before the Cottonwood period successful angel investor. Expert in strategy, marketing, product launching, pricing and international business acceleration.
In the past Alain was one of the founders of the European Accelerator Program for the European Institute for Technology and Innovation and coached more than 200 high-tech startups in Europe.
Alain has a huge network and direct access to lots of corporates and all relevant ecosystems in Europe (Paris, Berlin, London, Helsinki, Stockholm, Leuven, Munich, etc.).
Alain graduated in 2001 cum laude for an Executive MBA at Business School Nederland.
Alan is Chairman of Sunland Optical Company, Inc. and serves on the boards of Innovate El Paso/Regional Center for Innovation and Commercialization (RCIC) and The HUB of Human Innovation, Investment Committee for the Paso del Norte Health.
Alan is Special LP in Cottonwood Fund I, Fund II and the Euro Fund.
Alan was appointed by the Governor of Texas as a founding Director of the Emerging Technology Fund. Alan is Board Member and past Chairmain of Investment, Audit and Finance Committees at Paso del Norte Health Foundation.
Alan is Board Director of the Western Heritage Bank, Board Director at New Mexico First Financial, Inc. and Member of the Board of Directors of El Paso Children’s Hospital.
A graduate of Stanford University, Alan studied at the Florence, Italy campus and holds an MBA from the University of Texas at El Paso. He is also CPA.
Marie Weijler LL.M. M.A. worked between 2015 and 2019 as a Senior Manager at private investors network Princip.al. She expanded the network from 450 to 1,500 single family offices and private equity firms. She also sourced more than 100 investment projects in high-tech industries for her clients.
Starting with Fund III, Marie Weijler will contribute to the further expansion of Cottonwood Technology Fund in Europe. Her main tasks will include investor relations, ESG performance, compliance and deal sourcing.
In 2019, she was included in the annual Forbes 30 Under 30 Europe list in the Finance category. She is the first Dutch citizen who made it to the list in this category.
Marie Weijler graduated from Leiden University’s renowned law school with a specialization in Corporate Law. Furthermore, she earned a master’s degree in European Studies from KU Leuven, Belgium’s highest-ranked university.
Shinjan Dasgupta has over 16+ years of combined experience in the Manufacturing and Technology sector.
Shinjan graduate with a degree in Engineering from the University of Madras. His expertise include technical research, market research, business development and product development.
Shinjan has had the opportunity to work as an analyst for startups, scaleups as well and also Fortune 500 companies. Shinjan joined in 2019 Cottonwood Technology Fund.
Charles serves as an Special LP in Cottonwood Funds I and II, sourcing both the Skorpios and Incitor.
Charles is also General Partner in Phase One Ventures, a small ($2M) angel fund, and an active angel investor.
Charles holds a BS in Chemical Engineering with Highest Honors from Montana State University and am MS and PhD in Mechanical Engineering from the University of California, Davis. Charles was previously employed by the Lawrence Livermore National Lab.
Specialties: General management, leadership coaching, start-ups. intellectual property management, technology commercialization and business development.